AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BATM Advanced Communications Ltd.

Pre-Annual General Meeting Information Sep 14, 2017

6682_rns_2017-09-14_fa9e1595-7a86-42da-88db-bda2c60ec16a.html

Pre-Annual General Meeting Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6923Q

BATM Advanced Communications Ld

14 September 2017

14 September 2017

BATM Advanced Communications Limited

("BATM" or the "Company")

Notice of AGM

and

Grant of Options

BATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, gives notice that the Annual General Meeting ("AGM" or the "Meeting") of the Company is to be held at the offices of Luther Pendragon Limited, 48 Gracechurch Street, London, EC3V 0EJ on 18 October 2017 at 10.00am BST.

The Notice of AGM circular has been posted to shareholders of the Company today and includes information on the resolutions to be considered at the Meeting, along with forms of proxy and direction, which are also available on BATM's website: www.batm.com.

Among the items to be considered at the AGM is the grant of the following long-term incentives to Dr Zvi Marom, CEO of the Company, conditional on independent shareholder approval:

▪     A grant of five million options to purchase BATM ordinary shares of NIS 0.01 each.

▪     The exercise price per share will be 18.261 pence per share being the average price of the Company's shares on the London Stock Exchange in the month preceding the date of board approval (being 13 September 2017).

▪     Half of the options will vest at the end of 24 months from the date of grant and the other half at the end of 36 months, provided that Dr Marom remains in his position at the Company as at the date of each vesting.

The total number of options over ordinary shares to be granted represents 1.24% of the current issued share capital of 403,150,820 ordinary shares. Dr Marom holds 23.98% of the current issued share capital.  

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Enquiries:

ATM Advanced Communications
Dr Zvi Marom, Chief Executive Officer +972 9866 2525
Moti Nagar, Chief Financial Officer
Shore Capital
Mark Percy, Anita Ghanekar +44 20 7408 4050
Luther Pendragon
Harry Chathli, Claire Norbury +44 20 7618 9100

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCOKNDNOBKDBCD

Talk to a Data Expert

Have a question? We'll get back to you promptly.